Those in-depth studies of the health system of member countries focus on economic issues. They assess the performance of health systems in a comparative context, identify the main challenges faced by the country health system and put forward policy options to better meet them. Reviews are initiated at the request of the country to be examined and emphasis is placed on specific issues of key policy interest.
This new OECD series aims to highlight the latest data in selected countries, to explain their health care systems and to provide key information in a clear and concise way. Each country snapshot highlights the most pertinent issues, be it smoking, obesity, surgical interventions, consumption of antibiotics, physicians density, etc., with the help of key statistics and are followed by brief policy recommendations.
English, PDF, 346kb
Finland appears to have a high performing health system, with remarkable good quality in both primary and hospital care. The country also achieves good health status at relatively low level of health spending. Despite these advances, there are specific areas where improvements can be made such as preventing the spread of obesity and addressing gaps in mental health.
Specific country notes have been prepared using data from the database OECD Health Statistics 2015, July 2015 version. The notes are available in PDF format.
Across OECD countries some 83 million people suffer from diabetes. On current trends, that will rise to almost 100 million by 2030.
This report reviews the impact of pay increases on nurses’ labour market in four countries (UK, New Zealand, Finland and Czech Republic). Pay increases contributed to an increase in potential new entrants to nurse education, but the effect on nurses already in work is more difficult to assess.
The mortality amenable to health care is defined as a possible indicator to measure the health care systems performance in preventing premature deaths that can be avoided by appropriate health care intervention. This paper assesses the feasibility of using this indicator in OECD countries.
Summarises proceedings of a conference looking at examples of human genetic research databases, how they are established, how they are managed and governed, how they might be commercialised, and what the policy considerations might be.
This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries. Based on rich evidence, it draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.